Copertina

Inflammasomes in Atherosclerosis-From Pathophysiology to Treatment

Atherosclerosis, a chronic inflammatory disease characterized by arterial plaque accumulation, remains a significant global health challenge. In recent years, inflammasomes, the intracellular multiprotein complexes crucial for initiating innate immune responses, have emerged as key players in athero...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Panagiotis Theofilis (Autore), Evangelos Oikonomou (Autore), Christos Chasikidis (Autore), Konstantinos Tsioufis (Autore), Dimitris Tousoulis (Autore)
Natura:	Libro
Pubblicazione:	MDPI AG, 2023-08-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The impact of SGLT2 inhibition on imaging markers of cardiac function: A systematic review and meta-analysis
di: Panagiotis Theofilis, et al.
Pubblicazione: (2022)

Novel Treatments in Refractory Recurrent Pericarditis
di: Emilia Lazarou, et al.
Pubblicazione: (2024)

The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis
di: Xiao-Dan Xu, et al.
Pubblicazione: (2022)

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
di: Pengfei Chen, et al.
Pubblicazione: (2024)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
di: Tadayoshi Karasawa, et al.
Pubblicazione: (2017)

Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy
di: Vlachakis PK, et al.
Pubblicazione: (2024)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
di: Xiao-Nan Zhang, et al.
Pubblicazione: (2022)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
di: Jiang C, et al.
Pubblicazione: (2021)

Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis
di: Chih-Feng Lien, et al.
Pubblicazione: (2021)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
di: Laura Hurtado-Navarro, et al.
Pubblicazione: (2022)

AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.
di: Georgiopoulos Georgios, et al.
Pubblicazione: (2016)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
di: Eleftheria Galatou, et al.
Pubblicazione: (2022)

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
di: Clio P. Mavragani, et al.
Pubblicazione: (2012)

From Pathophysiology to Treatment of Huntington's Disease
Pubblicazione: (2022)

New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
di: Simona Fecarotta, et al.
Pubblicazione: (2018)

Migraine Pathophysiology and Treatment
di: J Gordon Millichap
Pubblicazione: (1999)

Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics
di: Stavros P. Papadakos, et al.
Pubblicazione: (2023)

From Proteinuria to Fibrosis: An Update on Pathophysiology and Treatment Options
di: Sonia Sharma, et al.
Pubblicazione: (2021)

Selenium and thyroid dysfunction: from pathophysiology to treatment options
di: Ekaterina N. Dudinskaya
Pubblicazione: (2024)

Renal disease pathophysiology and treatment: contributions from the rat
di: Linda J. Mullins, et al.
Pubblicazione: (2016)

Neuromyelitis Optica Spectrum Disorders - from pathophysiology to treatment
di: Jessica Adriana Kałuża, et al.
Pubblicazione: (2024)

STING-Associated Vasculopathy with Onset in Infancy: A Review Focusing on Pathophysiology and Treatment Options
di: Konstantinos Drougkas, et al.
Pubblicazione: (2023)

The Prevention and Treatment of Atherosclerosis
Pubblicazione: (2022)

Maternal syphilis: pathophysiology and treatment
di: Berman Stuart M.
Pubblicazione: (2004)

Bicuspid Aortic Valve, Bovine Aortic Arch and early Atherosclerosis: When one plus one equals three
di: E Chatzistamatiou, et al.
Pubblicazione: (2017)

Editorial: Orofacial Pain of Muscular Origin-From Pathophysiology to Treatment
di: Nikolaos Christidis, et al.
Pubblicazione: (2022)

Vestibular Migraine: from Differential Diagnosis and Pathophysiology to Treatment Options
di: Farzaneh Zamiri Abdollahi, et al.
Pubblicazione: (2018)

Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-κB-NLRP3 inflammasome pathway
di: Yanyan Cen, et al.
Pubblicazione: (2023)

Dermoscopy as a Tool in Differentiating Cutaneous Squamous Cell Carcinoma From Its Variants
di: Dimitrios Sgouros, et al.
Pubblicazione: (2021)

Sonodynamic therapy for the treatment of atherosclerosis
di: Yan Zhang, et al.
Pubblicazione: (2024)

Role of naringin in the treatment of atherosclerosis
di: Yan Lu, et al.
Pubblicazione: (2024)

Sepsis and the muscle tissue. A narrative review
di: Oikonomou Eleousa, et al.
Pubblicazione: (2021)

Metabolic syndrome - diagnostics, pathophysiology and treatment
di: Weronika Wasyluk, et al.
Pubblicazione: (2019)

Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia
di: Mihnea-Alexandru Găman, et al.
Pubblicazione: (2017)

Metabolic syndrome - diagnostics, pathophysiology and treatment
di: Weronika Wasyluk, et al.
Pubblicazione: (2019)

Pathophysiology, prognosis and treatment of tardive dyskinesia
di: Hiroyoshi Takeuchi, et al.
Pubblicazione: (2022)

Erythropoiesis: insights into pathophysiology and treatments in 2017
di: Andrea Zivot, et al.
Pubblicazione: (2018)

Osteoporosis - pathophysiology, symptoms, prevention and treatment
di: Agnieszka Dobosz, et al.
Pubblicazione: (2020)

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
di: Ioannis A. Vathiotis, et al.
Pubblicazione: (2021)

Inflammasomes and dermatology
di: Daniel Coelho de Sá, et al.
Pubblicazione: (2016)